<VariationArchive RecordType="classified" VariationID="2506526" VariationName="GRCh37/hg19 2q24.3(chr2:166872248-167334216)" VariationType="copy number loss" Accession="VCV002506526" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2023-07-01" MostRecentSubmission="2023-07-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2671486" VariationID="2506526">
      <GeneList>
        <Gene Symbol="SCN1A" FullName="sodium voltage-gated channel alpha subunit 1" GeneID="6323" HGNC_ID="HGNC:10585" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165984641" stop="166149161" display_start="165984641" display_stop="166149161" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166845669" stop="167005641" display_start="166845669" display_stop="167005641" Strand="-" />
          </Location>
          <OMIM>182389</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN1A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN1A">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="SCN7A" FullName="sodium voltage-gated channel alpha subunit 7" GeneID="6332" HGNC_ID="HGNC:10594" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="166403573" stop="166494249" display_start="166403573" display_stop="166494249" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="167260082" stop="167343480" display_start="167260082" display_stop="167343480" Strand="-" />
          </Location>
          <OMIM>182392</OMIM>
        </Gene>
        <Gene Symbol="SCN9A" FullName="sodium voltage-gated channel alpha subunit 9" GeneID="6335" HGNC_ID="HGNC:10597" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="166195185" stop="166375987" display_start="166195185" display_stop="166375987" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="167051694" stop="167232496" display_start="167051694" display_stop="167232496" Strand="-" />
          </Location>
          <OMIM>603415</OMIM>
        </Gene>
      </GeneList>
      <Name>GRCh37/hg19 2q24.3(chr2:166872248-167334216)</Name>
      <VariantType>copy number loss</VariantType>
      <Location>
        <CytogeneticLocation>2q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" innerStart="166872248" innerStop="167334216" display_start="166872248" display_stop="167334216" />
      </Location>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="GRCh37/hg19 2q24.3(chr2:166872248-167334216) AND Severe myoclonic epilepsy in infancy" Accession="RCV003236710" Version="1">
        <ClassifiedConditionList TraitSetID="1766">
          <ClassifiedCondition DB="MedGen" ID="C0751122">Severe myoclonic epilepsy in infancy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-26" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-07-01" MostRecentSubmission="2023-07-01">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="1766" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4140" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 6 (Dravet syndrome)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 6A</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epilepsy, Myoclonic, Infantile, Severe</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dravet syndrome</ElementValue>
                <XRef ID="MONDO:0100135" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe myoclonic epilepsy in infancy</ElementValue>
                <XRef ID="219513" DB="GeneTests" />
                <XRef ID="Dravet+Syndrome/2332" DB="Genetic Alliance" />
                <XRef ID="230437002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ICE-GTC</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">DEE6A</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EIEE6</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DRVT</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SMEI</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SME</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">SCN1A seizure disorders encompass a spectrum that ranges from simple febrile seizures and generalized epilepsy with febrile seizures plus (GEFS+) at the mild end to Dravet syndrome and intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC) at the severe end. Phenotypes with intractable seizures including Dravet syndrome are often associated with cognitive decline. Less commonly observed phenotypes include myoclonic astatic epilepsy (MAE), Lennox-Gastaut syndrome, infantile spasms, epilepsy with focal seizures, and vaccine-related encephalopathy and seizures. The phenotype of SCN1A seizure disorders can vary even within the same family.</Attribute>
                <XRef ID="NBK1318" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301494</ID>
                <ID Source="BookShelf">NBK1318</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2008">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_Dravet.pdf</URL>
                <CitationText>Orphanet, Dravet syndrome, 2008</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <Citation Type="Suggested Reading">
                <ID Source="PubMed">28880996</ID>
              </Citation>
              <XRef ID="33069" DB="Orphanet" />
              <XRef ID="C0751122" DB="MedGen" />
              <XRef ID="MONDO:0100135" DB="MONDO" />
              <XRef Type="MIM" ID="607208" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7356752" SubmissionDate="2023-05-29" DateLastUpdated="2023-07-01" DateCreated="2023-07-01">
        <ClinVarSubmissionID localKey=":Chr.2_166872248_167334216_copy number loss|OMIM:607208" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003935209" DateUpdated="2023-07-01" DateCreated="2023-07-01" Type="SCV" Version="1" SubmitterName="Laboratory of Medical Genetics, National &amp; Kapodistrian University of Athens" OrgID="506664" OrganizationCategory="laboratory" OrgAbbreviation="LMG-NKUA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG/ClinGen CNV Guidelines, 2019</Attribute>
          <Citation>
            <ID Source="PubMed">31690835</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>copy number loss</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" innerStart="166872248" innerStop="167334216" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607208" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13480173</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7356752" TraitType="Disease" MappingType="XRef" MappingValue="607208" MappingRef="OMIM">
        <MedGen CUI="C0751122" Name="Severe myoclonic epilepsy in infancy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

